Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm.
| Publicado en: | Targeted Oncology Vol. 15; no. 4; pp. 531 - 541 |
|---|---|
| Autores principales: | , , , , |
| Formato: | Journal Article |
| Publicado: |
Springer Nature
Aug2020
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=145258645&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 145258645 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17762596 47DQ jtl: Targeted Oncology issn: 17762596 maglogo: N pubinfo: dt: Aug2020 vid: 15 iid: 4 pid: 237 pub: Springer Nature place: New York, New York artinfo: ui: 145258645 144469380 10.1007/s11523-020-00735-9 145258645 ppf: 531 ppct: 10 formats: fmt: – @attributes: type: T – @attributes: type: P tig: atl: Clinical Relevance of BRAF V600E Mutation Status in Brain Tumors with a Focus on a Novel Management Algorithm. aug: au: Kowalewski, Adam Durślewicz, Justyna Zdrenka, Marek Grzanka, Dariusz Szylberg, Łukasz affil: Department of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Torun, Poland sug: pubtype: Academic Journal doctype: Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|